Pharmacokinetic and Pharmacodynamics Study of Multiple Oral Doses of Vildagliptin Sustained Release 100 Mg Tablets under the Fed State in Healthy Volunteers.

Autor: Doshi, Chetan, Sridhar, S. B., Birla, Ashish, Prasad, Ashish, Kadam, Pramod, Warrier, Sona

Publikováno v: Journal of Drug Delivery & Therapeutics; Sep2023, Vol. 13 Issue 9, p107-113, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study.

Autor: Erande S; Diabetes and Endocrinology, Akshay Hospital & Diabetic Speciality Centre, Pune, IND., Mukhopadhyay J; General Medicine, Institute of Post Graduate Medical Education & Research, Kolkata, IND., Dange A; Medicine, LifeTree Hospital, Pune, IND., Deogaonkar A; Medicine, Akshay Hospital, Pune, IND., Birla A; Scientific Services, USV Private Limited, Mumbai, IND., Doshi C; Research and Development (R&D), USV Private Limited, Mumbai, IND., Revankar S; Scientific Services, USV Private Limited, Mumbai, IND., B SS; Clinical Research, USV Private Limited, Mumbai, IND., Kumar N; Scientific Services, USV Private Limited, Mumbai, IND., Kadam PV; Clinical Research, USV Private Limited, Mumbai, IND.

Publikováno v: Cureus [Cureus] 2023 Sep 01; Vol. 15 (9), pp. e44548. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).